253 related articles for article (PubMed ID: 28982690)
1. Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling.
Emdin CA; Khera AV; Klarin D; Natarajan P; Zekavat SM; Nomura A; Haas M; Aragam K; Ardissino D; Wilson JG; Schunkert H; McPherson R; Watkins H; Elosua R; Bown MJ; Samani NJ; Baber U; Erdmann J; Gormley P; Palotie A; Stitziel NO; Gupta N; Danesh J; Saleheen D; Gabriel S; Kathiresan S
Circulation; 2018 Jan; 137(3):222-232. PubMed ID: 28982690
[TBL] [Abstract][Full Text] [Related]
2. Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy.
Guey S; Hervé D; Kossorotoff M; Ha G; Aloui C; Bergametti F; Arnould M; Guenou H; Hadjadj J; Dubois Teklali F; Riant F; Balligand JL; Uzan G; Villoutreix BO; Tournier-Lasserve E
Hum Genomics; 2023 Mar; 17(1):24. PubMed ID: 36941667
[TBL] [Abstract][Full Text] [Related]
3. Functional Characterization of the
Kessler T; Wobst J; Wolf B; Eckhold J; Vilne B; Hollstein R; von Ameln S; Dang TA; Sager HB; Moritz Rumpf P; Aherrahrou R; Kastrati A; Björkegren JLM; Erdmann J; Lusis AJ; Civelek M; Kaiser FJ; Schunkert H
Circulation; 2017 Aug; 136(5):476-489. PubMed ID: 28487391
[TBL] [Abstract][Full Text] [Related]
4. Paracrine nitric oxide induces expression of cardiac sarcomeric proteins in adult progenitor cells through soluble guanylyl cyclase/cyclic-guanosine monophosphate and Wnt/β-catenin inhibition.
De Pauw A; Massion P; Sekkali B; Andre E; Dubroca C; Kmecova J; Bouzin C; Friart A; Sibille C; Gilon P; De Mulder D; Esfahani H; Strapart A; Martherus R; Payen V; Sonveaux P; Brouckaert P; Janssens S; Balligand JL
Cardiovasc Res; 2016 Oct; 112(1):478-90. PubMed ID: 27520736
[TBL] [Abstract][Full Text] [Related]
5. Stimulators of the soluble guanylyl cyclase: promising functional insights from rare coding atherosclerosis-related GUCY1A3 variants.
Wobst J; von Ameln S; Wolf B; Wierer M; Dang TA; Sager HB; Tennstedt S; Hengstenberg C; Koesling D; Friebe A; Braun SL; Erdmann J; Schunkert H; Kessler T
Basic Res Cardiol; 2016 Jul; 111(4):51. PubMed ID: 27342234
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation at the coronary artery disease risk locus GUCY1A3 modifies cardiovascular disease prevention effects of aspirin.
Hall KT; Kessler T; Buring JE; Passow D; Sesso HD; Zee RYL; Ridker PM; Chasman DI; Schunkert H
Eur Heart J; 2019 Nov; 40(41):3385-3392. PubMed ID: 31228190
[TBL] [Abstract][Full Text] [Related]
7. Dysfunctional nitric oxide signalling increases risk of myocardial infarction.
Erdmann J; Stark K; Esslinger UB; Rumpf PM; Koesling D; de Wit C; Kaiser FJ; Braunholz D; Medack A; Fischer M; Zimmermann ME; Tennstedt S; Graf E; Eck S; Aherrahrou Z; Nahrstaedt J; Willenborg C; Bruse P; Brænne I; Nöthen MM; Hofmann P; Braund PS; Mergia E; Reinhard W; Burgdorf C; Schreiber S; Balmforth AJ; Hall AS; Bertram L; Steinhagen-Thiessen E; Li SC; März W; Reilly M; Kathiresan S; McPherson R; Walter U; ; Ott J; Samani NJ; Strom TM; Meitinger T; Hengstenberg C; Schunkert H
Nature; 2013 Dec; 504(7480):432-6. PubMed ID: 24213632
[TBL] [Abstract][Full Text] [Related]
8. Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention.
Kessler T; Wolf B; Eriksson N; Kofink D; Mahmoodi BK; Rai H; Tragante V; Åkerblom A; Becker RC; Bernlochner I; Bopp R; James S; Katus HA; Mayer K; Munz M; Nordio F; O'Donoghue ML; Sager HB; Sibbing D; Solakov L; Storey RF; Wobst J; Asselbergs FW; Byrne RA; Erdmann J; Koenig W; Laugwitz KL; Ten Berg JM; Wallentin L; Kastrati A; Schunkert H
Cardiovasc Res; 2019 Aug; 115(10):1512-1518. PubMed ID: 30768153
[TBL] [Abstract][Full Text] [Related]
9. Functional polymorphisms of
Pereira DA; Luizon MR; Palei AC; Tanus-Santos JE; Cavalli RC; Sandrim VC
Front Genet; 2024; 15():1293082. PubMed ID: 38469120
[TBL] [Abstract][Full Text] [Related]
10. Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.
Wallace S; Guo DC; Regalado E; Mellor-Crummey L; Bamshad M; Nickerson DA; Dauser R; Hanchard N; Marom R; Martin E; Berka V; Sharina I; Ganesan V; Saunders D; Morris SA; Milewicz DM
Clin Genet; 2016 Oct; 90(4):351-60. PubMed ID: 26777256
[TBL] [Abstract][Full Text] [Related]
11. Associations between GUCY1A3 genetic polymorphisms and large artery atherosclerotic stroke risk in Chinese Han population: a case-control study.
Li JL; Liu LY; Jiang DD; Jiang YY; Zhou GQ; Mo DC; Luo M
Lipids Health Dis; 2019 Dec; 18(1):233. PubMed ID: 31883534
[TBL] [Abstract][Full Text] [Related]
12. NOS3 polymorphisms, cigarette smoking, and cardiovascular disease risk: the Atherosclerosis Risk in Communities study.
Lee CR; North KE; Bray MS; Avery CL; Mosher MJ; Couper DJ; Coresh J; Folsom AR; Boerwinkle E; Heiss G; Zeldin DC
Pharmacogenet Genomics; 2006 Dec; 16(12):891-9. PubMed ID: 17108813
[TBL] [Abstract][Full Text] [Related]
13. Interactions between the genes of vasodilatation pathways influence blood pressure and nitric oxide level in hypertension.
Kumar R; Kohli S; Mishra A; Garg R; Alam P; Stobdan T; Nejatizadeh A; Gupta M; Tyagi S; Pasha MA
Am J Hypertens; 2015 Feb; 28(2):239-47. PubMed ID: 25159081
[TBL] [Abstract][Full Text] [Related]
14. Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study.
Conen D; Glynn RJ; Buring JE; Ridker PM; Zee RY
J Hypertens; 2008 Sep; 26(9):1780-6. PubMed ID: 18698212
[TBL] [Abstract][Full Text] [Related]
15. Screening of the NOS3 gene identifies the variants 894G/T, 1998C/G and 2479G/A to be associated with acute onset ischemic stroke in young Asian Indians.
Akhter MS; Biswas A; Rashid H; Devi L; Behari M; Saxena R
J Neurol Sci; 2014 Sep; 344(1-2):69-75. PubMed ID: 24986538
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study.
Zhang X; Lynch AI; Davis BR; Ford CE; Boerwinkle E; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
PLoS One; 2012; 7(3):e34217. PubMed ID: 22470539
[TBL] [Abstract][Full Text] [Related]
17. Glu298Asp variant of the endothelial nitric oxide synthase gene and acute coronary syndrome or premature coronary artery disease: A systematic review and meta-analysis.
Rai H; Fitzgerald S; Coughlan JJ; Spence M; Colleran R; Joner M; Byrne RA
Nitric Oxide; 2023 Sep; 138-139():85-95. PubMed ID: 37451608
[TBL] [Abstract][Full Text] [Related]
18. Variants within the nitric oxide synthase 1 gene are associated with stroke susceptibility.
Manso H; Krug T; Sobral J; Albergaria I; Gaspar G; Ferro JM; Oliveira SA; Vicente AM
Atherosclerosis; 2012 Feb; 220(2):443-8. PubMed ID: 22153699
[TBL] [Abstract][Full Text] [Related]
19. Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease.
Emdin CA; Khera AV; Natarajan P; Klarin D; Zekavat SM; Hsiao AJ; Kathiresan S
JAMA; 2017 Feb; 317(6):626-634. PubMed ID: 28196256
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide meta-analysis identifies 3 novel loci associated with stroke.
Malik R; Rannikmäe K; Traylor M; Georgakis MK; Sargurupremraj M; Markus HS; Hopewell JC; Debette S; Sudlow CLM; Dichgans M;
Ann Neurol; 2018 Dec; 84(6):934-939. PubMed ID: 30383316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
